EMP2 and lung carcinoma: We employed wild-type and EMP2-overexpressing lung cancer cells, including A549, H520, NCI-H1703, and lung cancer cell lines with high EMP2 expression, NCI-H226 and SK-MES-1, to test the cytotoxicity of FK002-exatecan.